Safety of guselkumab treatment for up to 5 years in patients with moderate-to-severe psoriasis: pooled analyses across seven clinical trials with more than 8600 patient-years of exposure

Mark G. Lebwohl*, Joseph F. Merola, Katelyn Rowland, Megan Miller, Ya Wen Yang, Jenny Yu, Yin You, Daphne Chan, Diamant Thaçi, Richard G. Langley

*Korrespondierende/r Autor/-in für diese Arbeit
5 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Safety of guselkumab treatment for up to 5 years in patients with moderate-to-severe psoriasis: pooled analyses across seven clinical trials with more than 8600 patient-years of exposure“. Zusammen bilden sie einen einzigartigen Fingerprint.

Medizin & Biologie